(C) 2008 Elsevier Ltd. All rights reserved.”
“Pituitary adenylate cyclase activating Copanlisib cost polypeptide (PACAP) is a multifunctional neuropeptide with well-known neuroprotective and neurotrophic effects. The involvement of PACAP in sensory processing has also been documented, but little is known about its effects in the auditory system. PACAP and its specific receptor (PAC1) are present in the cochlea and in brain structures involved in auditory pathways. Recently, we have shown that PACAP protects cochlear cells against oxidative stress-induced apoptosis. The endolymphatic Ca2+ concentration controlled by Ca2+
buffers of the hair cells is essential for the normal hearing processes. In this study we examined the localization of PAC1 receptor and Ca2+ buffering proteins (parvalbumin, calretinin, calbindin) in the inner ear of 5-day-old PACAP-deficient mice compared with wild-type mice in order to get a closer insight into the effect of endogenous PACAP in the cochlear function. Selleck AZD9291 We did not find differences in the distribution pattern of PAC1 receptors between the two groups, but wild-type animals showed significantly higher PAC1 receptor expression. In contrast, inner and outer hair cells of PACAP-deficient mice showed more pronounced parvalbumin, calbindin, and calretinin immunopositivity compared with wild-type mice.
Elevated endolymphatic Ca2+ is deleterious for cochlear function, while the high concentration of Ca2+ buffers in hair cells may offer protection. The increased immunoreactivity of Ca2+ binding proteins in the absence of PACAP provide further evidence the important role of PACAP in the hearing
processes.”
“Background: Because balanced steady-state free precession (SSFP) sequences are opposed-phase gradient echo techniques, linear low signal due to chemical shift artefact is observed at fat-water interfaces. We observed that some patients with chronic myocardial Cell Cycle inhibitor infarctions had linear low signal along the inner myocardial wall in areas of infarction, which we postulated was due to chemical shift artefact, as a result of lipomatous metaplasia. The purpose of this retrospective review was to evaluate whether subendocardial low signal on SSFP, likely related to chemical shift artifact, could be used to identify chronic myocardial infarctions.
Methods: Of 128 patients who underwent cardiac magnetic resonance, 79 with myocardial infarctions were included in this retrospective study.
Results: Of the 79 patients, 35 (44%) demonstrated areas of linear subendocardial decreased signal. In 16 of those 35 (46%), the infarcts were confirmed as fatty by correlation with CT. In 29 of 35 (83%) of these patients, the infarcts were likely chronic based on fixed wall thinning to less than 4 mm.